CN105362653A

CN105362653A - Traditional Chinese medicine for treating hypotension

Info

Publication number: CN105362653A
Application number: CN201410420350.3A
Authority: CN
Inventors: 李月梅
Original assignee: Individual
Current assignee: Individual
Priority date: 2014-08-25
Filing date: 2014-08-25
Publication date: 2016-03-02

Abstract

The invention belongs to the technical field of traditional Chinese medicine and particularly relates to a traditional Chinese medicine for treating hypotension. The traditional Chinese medicine for treating hypotension is used for nourishing the blood and calming the liver and relieving dizziness and stopping pain. The traditional Chinese medicine is prepared from Astragalus Root, cornu cervi, poria cocos, atractylodes macrocephala koidz, dried tangerine or orange peel, polygonatum kingianum, fructus schizandrae, radix angelica sinensis, radix ophiopogonis, red ginseng, donkey-hide gelatin, honey-fried licorice roots, rhizoma cimicifugae, bupleurum and cassia twigs.

Description

One treats hypotensive Chinese medicine

Technical field

The invention belongs to technical field of Chinese medicines, particularly relate to one and treat hypotensive Chinese medicine.

Background technology

General silent hypotension is expected to be gone up by dietetic therapy and physical training.If blood pressure is for a long time lower than normal value, and with symptoms such as asthenia, weak, dizzy, cardiopalmus, pareordia weight senses, then need to coordinate Drug therapy.Primary disease belongs to the category such as " dizzy ", " empty virtue ", " fainting " of the traditional Chinese medical science.

The traditional Chinese medical science is thought that hypotension and congenital defect, the day after tomorrow lose and is supported, and just, the factors such as consumption of losing blood gas are relevant, and in treatment, with benefiting vital QI and blood, elevate a turnable ladder is positive clearly, and complement benefit brain is main for overstrain wound.In the past very over a long time in, this area still lacks good therapeutic modality for hypotension, the doctor trained in Western medicine in the past modes such as the high sugar of injection that adopt is treated more, though some curative effects can be obtained, but untoward reaction to a certain degree and side effect are had to human body: the traditional Chinese medical science there is no specific medicament to hypotension in the past, BUZHONG YIQI WAN in current clinical general employing pharmacopeia is treated, but curative effect is poor, and cure rate is low.

Summary of the invention

The present invention is exactly for the problems referred to above, provides a kind of good effect, and medicine source is wide, the hypotensive Chinese medicine for the treatment of without any side effects.

For achieving the above object, the present invention is made up of following raw materials according: the Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi.

As a kind of preferred version, the Radix Astragali of the present invention, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi weight portion are: Radix Astragali 10-15 part, Cornu Cervi Pantotrichum 8-12 part, Poria 11-15 part, Rhizoma Atractylodis Macrocephalae 10-12 part, Pericarpium Citri Reticulatae 7-12 part, Rhizoma Polygonati 10-16 part, Fructus Schisandrae Chinensis 12-18 part, Radix Angelicae Sinensis 15-20 part, Radix Ophiopogonis 10-12 part, Radix Ginseng Rubra 10-15 part, Colla Corii Asini 10-15 part, Radix Glycyrrhizae Preparata 11-16 part, Rhizoma Cimicifugae 10-12 part, Radix Bupleuri 8-15 part, Ramulus Cinnamomi 10-16 part.

As another kind of preferred version, the Radix Astragali of the present invention, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi weight portion are: the Radix Astragali 10 parts, 12 parts, Cornu Cervi Pantotrichum, 11 parts, Poria, the Rhizoma Atractylodis Macrocephalae 12 parts, Pericarpium Citri Reticulatae 7 parts, Rhizoma Polygonati 10 parts, Fructus Schisandrae Chinensis 12 parts, Radix Angelicae Sinensis 18 parts, Radix Ophiopogonis 10 parts, Radix Ginseng Rubra 13 parts, 10 parts, Colla Corii Asini, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Cimicifugae 12 parts, Radix Bupleuri 8 parts, Ramulus Cinnamomi 16 parts.

In addition, raw material of the present invention also comprises weight portion and is: Radix Ginseng 7 parts, Cortex Cinnamomi 7 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20 parts, Endothelium Corneum Gigeriae Galli 20 parts.

Beneficial effect of the present invention.

Traditional Chinese medicine of the present invention is simple, rationally, good effect, medicine source is wide, without any side effects.Side's Chinese medicine reuses Radix Ginseng for monarch, minister with astragalus, Cornu Cervi Pantotrichum, help with night Siberian cocklebur, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, make with Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.We one monarch, two ministers, assistant seven, make one, play effect of benefiting qi and raising yang, nourishing YIN and benefiting blood altogether.

Detailed description of the invention

The present invention is made up of following raw materials according: the Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi.

The described Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi weight portion is: Radix Astragali 10-15 part, Cornu Cervi Pantotrichum 8-12 part, Poria 11-15 part, Rhizoma Atractylodis Macrocephalae 10-12 part, Pericarpium Citri Reticulatae 7-12 part, Rhizoma Polygonati 10-16 part, Fructus Schisandrae Chinensis 12-18 part, Radix Angelicae Sinensis 15-20 part, Radix Ophiopogonis 10-12 part, Radix Ginseng Rubra 10-15 part, Colla Corii Asini 10-15 part, Radix Glycyrrhizae Preparata 11-16 part, Rhizoma Cimicifugae 10-12 part, Radix Bupleuri 8-15 part, Ramulus Cinnamomi 10-16 part.

The described Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi weight portion are: the Radix Astragali 10 parts, 12 parts, Cornu Cervi Pantotrichum, 11 parts, Poria, the Rhizoma Atractylodis Macrocephalae 12 parts, Pericarpium Citri Reticulatae 7 parts, Rhizoma Polygonati 10 parts, Fructus Schisandrae Chinensis 12 parts, Radix Angelicae Sinensis 18 parts, Radix Ophiopogonis 10 parts, Radix Ginseng Rubra 13 parts, 10 parts, Colla Corii Asini, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Cimicifugae 12 parts, Radix Bupleuri 8 parts, Ramulus Cinnamomi 16 parts.

Raw material of the present invention also comprises weight portion: Radix Ginseng 7 parts, Cortex Cinnamomi 7 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20 parts, Endothelium Corneum Gigeriae Galli 20 parts.

One is treated hypotensive Clinical Action of Traditional Chinese Drugs and is summed up.

Physical data.

Chinese medicine of the present invention, clinical practice for many years, cures tens of routine hypotensive, age reckling 18 years old, the maximum 50 years old, the shortest person of the course of disease 2 years, most elder 30 years.Routine blood pressure of curing the disease all shows post lower than 90/60 millimeter, and with symptoms such as poor appetite, asthenia, weak, dizzy, cardiopalmus, pareordia weight senses.

Two, diagnostic criteria.

Systolic pressure shows post lower than 90 millimeters, and diastolic pressure shows post lower than 60 millimeters.

Three, method of administration.

Be decocted in water for oral dose, every day potion, sooner or later sub-service, taking continuously two weeks is a course for the treatment of, and unhealed takes a course for the treatment of again.

Four, points for attention.

Avoid pungent food and cold and cool food, take a good rest, Sufficient Sleeping, eating attention has additional nutrients.

Five, therapeutic effect.

Most of patients is taken medicine after the course for the treatment of, and blood pressure recovers normal, and asthenia, weak, dizzy, cardio palmus shape disappearance, small number of patients need be taken two courses for the treatment of and cure.

Diagnostic criteria, symptom score standard, efficacy determination and observational technique.

Case selection standard.

Diagnosis, dialectical standard.

Tcm diagnosis, dialectical: to formulate with reference to higher medical institution teaching material " Chinese Internal Medicine ", " Diagnostics of Chinese Medicine ", the chronic hypotension person of the deficiency of vital energy of all genus traditional Chinese medical science " dizzy " or " asthenia ", blood deficiency, deficiency in both Qi and blood, board syndrome of deficiency of kidney-YANG.All cards are dialectical as follows.

Syndrome of deficiency of QI: have a dizzy spell, deficiency of QI with disinclination to talk, fatigue and weakness, spontaneous perspiration, light red tongue, deficient pulse be unable.

Syndrome of deficiency of blood: the light mortar of dizziness and blurred vision, pale complexion, lip and nail, palpitation and insomnia, numb hand and foot, light red tongue, thready pulse without strength.

Deficiency in both Qi and blood is demonstrate,proved: above-mentioned syndrome of deficiency of QI adds syndrome of deficiency of blood.

Syndrome of yang deficiency of spleen and kidney: shallow complexion or impractical, aversion to cold and cold limbs, stool is completely rushed down, loss of appetite, light red tongue are fat, deep and weak pulse is unable.

Model case.

1, Wang, female, 22 years old, in June, 2007 went to a doctor.Patient have hypotension medical history.Appetite is poor usually, often feels fatigue and weak, dizziness, tired postemphasis.Have a medical check-up: patient's body constitution is thin and weak, shallow complexion, pale tongue, white and thin fur, deep,thready and forceless pulse, blood pressure 80/50 millimeter shows post.Examine as hypotension (deficient qi and blood), give treatment by Chinese herbs of the present invention, take a course for the treatment of, patient's appetite is promoted, conscious full of physical strength, and fatigue and weakness, cardio palmus disappear, and survey its blood pressure 110/70 millimeter and show post.Follow up a case by regular visits to so far, then do not recur.

Above content is the further description done the present invention in conjunction with concrete preferred implementation; can not assert that specific embodiment of the invention is confined to these explanations; for general technical staff of the technical field of the invention; without departing from the inventive concept of the premise; some simple deduction or replace can also be made, all should be considered as belonging to the protection domain that claims that the present invention submits to are determined.

Claims

1. one treats hypotensive Chinese medicine, it is characterized in that being made up of following raw materials according: the Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi.

2. according to claim 1, one treats hypotensive Chinese medicine, it is characterized in that the described Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi weight portion is: Radix Astragali 10-15 part, Cornu Cervi Pantotrichum 8-12 part, Poria 11-15 part, Rhizoma Atractylodis Macrocephalae 10-12 part, Pericarpium Citri Reticulatae 7-12 part, Rhizoma Polygonati 10-16 part, Fructus Schisandrae Chinensis 12-18 part, Radix Angelicae Sinensis 15-20 part, Radix Ophiopogonis 10-12 part, Radix Ginseng Rubra 10-15 part, Colla Corii Asini 10-15 part, Radix Glycyrrhizae Preparata 11-16 part, Rhizoma Cimicifugae 10-12 part, Radix Bupleuri 8-15 part, Ramulus Cinnamomi 10-16 part.

3. according to claim 2, one treats hypotensive Chinese medicine, it is characterized in that the described Radix Astragali, Cornu Cervi Pantotrichum, Poria, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Rhizoma Polygonati, Fructus Schisandrae Chinensis, Radix Angelicae Sinensis, Radix Ophiopogonis, Radix Ginseng Rubra, Colla Corii Asini, Radix Glycyrrhizae Preparata, Rhizoma Cimicifugae, Radix Bupleuri, Ramulus Cinnamomi weight portion are: the Radix Astragali 10 parts, 12 parts, Cornu Cervi Pantotrichum, 11 parts, Poria, the Rhizoma Atractylodis Macrocephalae 12 parts, Pericarpium Citri Reticulatae 7 parts, Rhizoma Polygonati 10 parts, Fructus Schisandrae Chinensis 12 parts, Radix Angelicae Sinensis 18 parts, Radix Ophiopogonis 10 parts, Radix Ginseng Rubra 13 parts, 10 parts, Colla Corii Asini, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Cimicifugae 12 parts, Radix Bupleuri 8 parts, Ramulus Cinnamomi 16 parts.

4. according to claim 3, one treats hypotensive Chinese medicine, it is characterized in that raw material also comprises weight portion and is: Radix Ginseng 7 parts, Cortex Cinnamomi 7 parts, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20 parts, Endothelium Corneum Gigeriae Galli 20 parts.